Cogent Biosciences, Inc.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation t…
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Cogent Biosciences, Inc. (COGT) to it's peer group.
Peer Group
CERE IDYA KURA CGEM LIFE ZNTL VTYX OLMA SANA SNDX FIXX LRMR MRSN PTGX MGTX KALV KROS ANAB
Compare Together
Loading...